Alfred Akirov serves as Executive at Protalix BioTherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Alfred Akirov has executed 18 insider transactions totaling $903.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 15, 2013 involved selling 2,330 shares valued at $11.8K.
Alfred Akirov currently holds 4,915,383 shares of Protalix BioTherapeutics, Inc. (PLX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alfred Akirov has been a net seller of PLX stock. They have purchased $0 and sold $903.3K worth of shares.
Alfred Akirov's most recent insider trade was on Aug 15, 2013, when they sold 2,330 shares at $5.07 per share.
Get notified when new Form 4 filings are submitted
| $5.08 |
| Discretionary |
| Aug 14, 2013 | PLX | $505.0K | Sale | 100,000 | $5.05 | Discretionary |
| Aug 14, 2013 | PLX | $25.4K | Sale | 5,000 | $5.07 | Discretionary |
| Mar 12, 2013 | PLX | $57.0K | Sale | 10,000 | $5.70 | Discretionary |
| Mar 11, 2013 | PLX | $57.2K | Sale | 10,000 | $5.72 | Discretionary |
| Mar 11, 2013 | PLX | $17.3K | Sale | 3,000 | $5.75 | Discretionary |
| Mar 11, 2013 | PLX | $1.7K | Sale | 300 | $5.79 | Discretionary |
| Mar 11, 2013 | PLX | $28.6K | Sale | 5,000 | $5.71 | Discretionary |
| Mar 8, 2013 | PLX | $11.3K | Sale | 1,898 | $5.95 | Discretionary |
| Mar 8, 2013 | PLX | $14.8K | Sale | 2,500 | $5.92 | Discretionary |
| Mar 8, 2013 | PLX | $14.8K | Sale | 2,500 | $5.91 | Discretionary |
| Mar 8, 2013 | PLX | $58.2K | Sale | 10,000 | $5.82 | Discretionary |
| Mar 7, 2013 | PLX | $19.7K | Sale | 3,435 | $5.73 | Discretionary |
| Mar 7, 2013 | PLX | $28.6K | Sale | 5,000 | $5.71 | Discretionary |
| Mar 6, 2013 | PLX | $4.0K | Sale | 700 | $5.71 | Discretionary |
| Mar 6, 2013 | PLX | $11.4K | Sale | 2,000 | $5.68 | Discretionary |
| Mar 6, 2013 | PLX | $11.4K | Sale | 2,000 | $5.69 | Discretionary |